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Hospital acquired infections with Staphylococcus aureus; especially methicillin resistant S.
aureus (MRSA) is a major cause of morbidity and mortality in the United States. The aim of
this study was compare the rates of MRSA infections between MRSA colonized and not-
colonized patients. A retrospective, electronic and paper chart review of all adult pa-
tients admitted to the intensive care unit (ICU) from 2007 to 2010 was screened for MRSA.
Endpoints were pyogenic pneumonia, sepsis, endocarditis, skin and soft tissue infections,
osteomyelitis and septic arthritis. Patients who were not screened for MRSA were excluded
from the study. A total of 1203 patients were admitted and screened for MRSA colonization
on admission to the ICU from 2007 to 2010. Two main groups were made for between
colonized and not-colonized based on MRSA screening. Fifty-seven (57) positive colonized
and 122 not-colonized patients' charts were randomly selected. The mean age of the study
population was 61.7 ± 18.4 (range, 19e94); there were 80 (44.69%) males and 99 (55.31%)
females. The occurrence of infection with MRSA with either lower respiratory tract
infection or blood stream infection identified on the time of ICU admission was similar for
patients with and without MRSA nasal colonization 3.51% vs. 2.46%; p ¼ 0.459. There was
no observed difference in the rates of MRSA infection between those who tested colonized
and not-colonized.
Copyright 2014, Beni-Suef University. Production and hosting by Elsevier B.V. All rights reserved.nal Medicine, Drexel/Saint Peters University Hospital, 254 Easton Avenue, New Brunswick,
732 247 4612.
Igbinosa).
i-Suef University
sevier
ity. Production and hosting by Elsevier B.V. All rights reserved.
b e n i - s u e f un i v e r s i t y j o u rn a l o f b a s i c a n d a p p l i e d s c i e n c e s 3 ( 2 0 1 4 ) 8 1e8 6821. Introduction
Staphylococcus aureus is one of the leading causes of hospital-
acquired infections (Richards et al., 1999a). It usually infects
lower respiratory tract infections and surgical site (Richards
et al., 1999b). It is the second leading cause of nosocomial,
bacteremia, cardiovascular infections and pneumonia
(Wisplinghoff et al., 2004), especially in individuals admitted
to the intensive care unit (ICU). S. aureus infections are very
difficult to treat due to rapidity of developing resistance to
antimicrobial drugs. Resistance to penicillin and newer b-
lactamase resistant antibiotics like methicillin and oxacillin
was found soon after theywere introduced in to clinical use in
1940s and 1960s respectively (Lowy, 2003); hence the term
methicillin resistant S. aureus (MRSA). Centers for Disease
Control and Prevention's (CDC's) data on National Nosocomial
Infections Surveillance network have shown that MRSA
represent >50% of S. aureus strains causing nosocomial in-
fections patients admitted to intensive care units (National
Nosocomial Infection Surveillance (NNIS) System, 2003). This
resistance pattern has spread as use of penicillin increased,
first between hospitals and then into the community. Hospi-
talizations that resulted in infections attributable to MRSA
steadily increased between 2000 and 2005, nearly doubling in
many areas in the United States (Zilberberg et al., 2008).
Similarly, MRSA has become a common infection in the
intensive care unit setting. At this time MRSA accounts for
more than 60% of S. aureus infections that occur in ICU (Na-
tional Nosocomial Infections Surveillance Calfee et al., 2008;
(NNIS) System, 2004).
A national survey of nasal colonization with S. aureus
conducted from 2001 to 2004 shows that colonization with S.
aureus decreased in 2003e2004 to 28.6% from a previous level
of 32.4% in 2001e2002 (Chambers, 2001). However prevalence
of MRSA colonization rose from 0.8% to 1.5% during this same
time period (Gorwitz et al., 2008). One reason for this obser-
vation may be increased antimicrobial use, such as fluo-
roquinolones, on suppression ofmethicillin sensitive S. aureus
(MSSA) more than MRSA, subsequently promoting coloniza-
tion of MRSA (Gorwitz et al., 2008). MRSA is now considered to
be endemic or even epidemic in major hospitals in the United
States as well as long-term facilities (Chambers, 2001). There
is an increase risk for health care-associated MRSA infection
among MRSA-colonized patients estimated to be almost 10
times that for patients who are not-colonized (Davis et al.,
2004). This relationship has been established in surgical pa-
tients and studies have shown that S. aureus carriers have
2e10 fold increased risk of developing an S. aureus surgical site
infection, mostly from the patient's endogenous flora (Davis
et al., 2004; Kluytmans et al., 1995).
To decrease the incidence of health care associated MRSA
infections, Society for Healthcare Epidemiology of America
(SHEA) recommends active surveillance cultures at the time of
hospital admission along with contact precautions for pa-
tients at high risk for MRSA carriage (Mangram et al., 1999;
Muto et al., 2003). Risk factors vary by geographical location
and demographic characteristics of the patient population but
Hidron et al. (2005) identified independent risk factors for
nasal colonization which include; hospitalization within thepast 12 months, the presence of a skin or soft-tissue infection
at admission, antimicrobial use within the 3 months before
admission, and HIV-seropositive status (Hidron et al., 2005).
Cultural strategies for curtailing the spread of MRSA have
centered on the prevention of cross-transmission, hand hy-
giene practices, cleaning and disinfection of the environment
as well as timely identification of patients colonized with
MRSA (Diekema and Climo, 2008). Nasal swabbing of all pa-
tients admitted to the hospital to detect asymptomatic patient
harboringMRSA, a process called active surveillance culturing
(ASC) has been tested with mixed result. ASC intend to iden-
tify MRSA carriers promptly so that contact precautions can
be instituted in a timely manner to decrease the frequency of
cross-transmission events to other patients. Many hospitals
in United States now screen patients upon ICU admission for
MRSA, using nasal swabs for MRSA detection by using poly-
merase chain reaction; some states have passed legislation
mandating all patients at risk for MRSA be screened on
admission, even-though Centers for Disease Control (CDC)
guidelines and recent infection control position statement
recommend against routine use of ASC to control MRSA
(Weber et al., 2007). The aim of this study was to compare the
rates of MRSA infections between MRSA colonized and not-
colonized patients with the hypothesis that; nasopharyngeal
colonization with MRSA does not predict subsequent MRSA
related infections in the ICU and that similar rate of MRSA
related infections between MRSA positive and MRSA negative
patients.2. Materials and methods
Approval of Institutional review board (IRB) was obtained
from Saint Peters University Hospital (SPUH). A retrospective,
electronic and paper chart review of all adult patients
admitted to the intensive care unit (ICU) from 2007 e2010 was
screened for MRSA. Data was also obtained from infection
prevention and control office database of SPUH that imple-
ments and records all data regarding MRSA screening. End-
points of this study were pyogenic pneumonia, sepsis,
endocarditis, skin and soft tissue infections, osteomyelitis and
septic arthritis. For each patient colonized with MRSA, two
randomly selected not-colonized patients were matched as
control. Demographics, etiology and place of residence prior
to hospitalization were obtained. Patients in both groups with
observed for subsequent MRSA related infections during their
ICU stay as well as re-hospitalization during the study period.
Patients whowere not screened for MRSA on admission to ICU
were excluded from the study.
Modified National Healthcare Safety Network (NHSH) def-
initions were used to define MRSA infections acquired in the
ICU (Horan et al., 2008). Only lower respiratory tract infections
(LRTIs) and bloodstream infections (BSIs) were evaluated,
because they account for the majority of ICU acquired MRSA
infection (National Nosocomial Infections Surveillance Horan
et al., 2008; (NNIS) System, 2004). LRTIs were defined as a
positive quantitative respiratory culture (>104 colony-forming
units per mL for bronchoalveolar lavage and >105 colony-
forming units per mL for tracheal aspirate or sputum, all
respiratory cultures were performed quantitatively. BSIs were
Table 1 e Sex and age distribution of population.
MRSA colonized P-values MRSA not-
colonized
P-values Total
(n) (%) (n) (%)
Sex
Male 22 38.59 p < 0.01 58 47.54 p < 0.01 80
Female 35 61.40 p < 0.01 64 52.46 p < 0.01 99
Total 57 122 179
Age
18e30 0 e 4 3.28 p < 0.05
31e45 4 7.02 p < 0.05 18 14.75 p < 0.05
46e60 5 8.77 p < 0.05 18 14.75 p < 0.05
61e75 13 22.81 p < 0.05 32 26.23 p < 0.05
>75 35 61.40 p < 0.05 50 40.98 p < 0.05
Total 57 122
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tures and a positive blood culture that was not related to an
infection at another site. ICU acquired MRSA infection was
defined as the development of MRSA infectionmore than 48 h
after ICU admission and less than 48 h after ICU discharge
(Schramm et al., 2006).
2.1. Screening of MRSA patients at Saint Peters
University Hospital (SPUH)
SPUH uses amplification methods for rapid MRSA detection.
The protocol for MRSA screening employed at SPUH is as
follows:
a) Both nares of all patients admitted to intensive care unit
are swab then, culturette sent to the laboratory for Poly-
merase chain reaction (PCR) analysis
P
.
b) If a positive MRSA history status was known on admission,
the patientwas place in private room; contact and resistant
organism precaution will be initiated.
c) When patients are identified as PCR screen positive, the
laboratory notifies the patient care unit and physician,
contact precaution is therefore initiated.
d) On each return admission, previous positive patients are
placed in isolation until negative status has been
determined.Table 2 e Result of MRSA screen at the time of ICU2.2. Statistical analysis
Chi-square and Fisher's exact tests was performed for all
variables. For all analyses a two-tailed p value of <0.05 or <0.01
was considered statistically significant.admission.
MRSA infection MRSA screen
Colonized Not colonized
(No.) % (No.) %
Positive 2(SC) 3.508 3(1 BC 2 SC) 2.46
Negative 55 96.49 119 97.54
Total 57 122
Legend: SC-sputum culture; BC- blood culture; ICU- intensive care
unit.3. Results
A total of 1203 patients were admitted and screened for MRSA
colonization on admission to the ICU from 2007 e 2010. Of
these 179 patients chart were randomly selected for review,
information regarding demographics, age, sex, place of resi-
dence, result of MRSA nasal swab and probable MRSA asso-
ciated infection were obtained. Table 1 shows age and sexdistribution of study population. The mean age of the study
population was 61.7 ± 18.4 (range, 19e94); there were 80
(44.69%) males and 99 (55.31%) females.
As shown in Table 2, two main groups were made colo-
nized and not colonized based on MRSA screening. Using
MRSA nasal swab polymerase chain reaction (PCR) as
screening tool. Fifty-seven (57) colonized and 122 not-
colonized patients' charts were randomly selected for anal-
ysis. Among those colonized 2 (3.51%) evidence of lower res-
piratory tract infection, there was no positive blood culture for
MRSA in this group. For the not-colonized group a total of 3
positive cultures 1 blood and 2 sputum (2.46%) were also
obtained. The occurrence of infection with MRSA with either
lower respiratory tract infections (LRTIs) or blood stream
(BSIs) infections identified on the time of ICU admission was
similar for patientswith andwithoutMRSA nasal colonization
3.51% vs. 2.46%; p ¼ 0.459.
Table 3 shows place of patients' residence prior to ICU
admission. Majority of patient's prior residence with and
without MRSA colonization was their homes (67.18%). The
likelihood of MRSA colonization was similar in both patients
presenting from nursing home (14.03% vs 14.75%; p ¼ 0.326);
however patients who presented from rehabilitation center
were more likely to be MRSA colonized (24.56% vs 12.29%;
p ¼ 0.265).
As shown in Table 4, sensitivity of admission MRSA nasal
swab to predict only lower respiratory tract infections (LRTIs)
was similar to either lower respiratory tract infections (LRTIs)
or blood stream infections (BSIs) (3.51% vs 3.51%; p ¼ 0.473).
Table 3 e Place of residence prior to ICU admission.
Place of residence MRSA screen
Positive Negative
(No.) % (No.) %
Home 35 61.40 89 72.95
Nursing home 8 14.03 18 14.75
Rehabilitation center 14 24.56 15 12.29
Total 57 122
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highest for prediction for lower respiratory tract infections
(LRTIs) 50.00% and lowest for blood stream infections (BSIs).
Negative predictive value the admission nasal swab for only
lower respiratory tract and both lower respiratory tract in-
fections and blood stream infections was similar 68.39% vs
68.39%; p ¼ 0.754. Disease prevalence was calculated to be
32.02% (95% CI: 25.24e39.42) (p > 0.01). The number of subse-
quent infections between those who are MRSA colonized (2
sputum cultures) versus MRSA not-colonized (1 blood culture
and 1 sputum culture) patients was similar. No clinical disease
attributed to MRSA was documented in both groups.4. Discussion
Several investigations have attempted to define the benefits of
routine MRSA surveillance as a strategy to prevent MRSA in-
fections among hospitalized patients. The findings have been
mixed, and the benefits of routine MRSA screening at the time
of hospital or ICU admission are still debated (Chaberny et al.,
2008; Diekema and Climo, 2008; Harbarth et al., 2008). Another
potential role for MRSA screening in the ICU is as a guide for
antimicrobial therapy of suspected infections. Previous
studies have demonstrated MRSA colonization is a risk factor
for subsequent infection with MRSA (Ellis et al., 2004;
Wertheim et al., 2004). Unfortunately the accuracy of MRSA
screening as a predictor for subsequent ICU acquired in-
fections requiring empirical antimicrobial coverage for MRSA
is unknown. This study have showed that MRSA nasal colo-
nization has a very low sensitivity (3.51%) and a poor predictor
of subsequent MRSA associated infection requiring antibiotics
at the time of ICU admission. The identification of MRSA
colonization would have improved if a more extensive sur-
veillance that include swabs obtained from rectum, stool,Table 4 e Sensitivity, specificity, and positive and negative pre
MRSA associated LRTI and BSI.
Sensitivity, %
(95% CI)
Specificity, %
(95% CI)
Positive predictive
value, % (95% CI)
MRSA nasal swabs
LRTI 3.51 (0.53e12.13) 98.35 (94.14e99.75) 50.00 (8.30e91.70)
BSI 0.00 (0.00e6.33) 99.17 (95.43e99.86) 0.00 (0.00e83.45)
Either LRTI
or BSI
3.51 (0.53e12.13) 97.54 (92.97e99.46) 40.00 (6.49e84.60)
SC-sputum culture; BC-blood culture; ICU-intensive care unit; CI-confide
infection.gastric aspirate and groin was done. We believe this is likely
the explanation for the poor performance of nasal swabs
alone in predicting subsequent MRSA infections.
Most studies of MRSA colonization among hospitalized
patients have focused on identifying MRSA colonization as
predictor of infection for the entire population cohort being
examined (Davis et al., 2004; Safdar and Bradley, 2008; Sakaki
et al., 2009). Croft et al. (2009) demonstrated that MRSA colo-
nizationwas a predictor of subsequent MRSA infection among
trauma patient. Chen et al. (2009) examined nasal carriage of
S. aureus in healthy children presenting with skin and soft
tissue infection. Safdar and Bradley (2008) performed a sys-
tematic review to provide an overall estimate of the risk of
MRSA infection after colonization with MRSA compared to
methicillin-susceptible S. aureus (MSSA). The authors
demonstrated that MRSA colonization was associated with
four-fold increase in the risk of infection compared to MSSA
colonization. Their analyses were four studies that evaluated
the role of MRSA colonization as a determinant of subse-
quently occurrence of MRSA infections in the ICU setting
(Fishbain et al., 2003; Squier et al., 2002).
Several studies have attempted to look at the benefits of
MRSA screening as a tool to predict subsequent infections and
as a strategy to prevent infections. However, the results have
shownmixed results and the benefits of screening at the time
of hospitalization or ICU admission is debatable (Kelly et al.,
2009; Sarikonda et al., 2010). The main point of contention
includes the efficacy of active surveillance culturing (ASC) and
judicious use of heath care resources as reported by Huskins
et al. (2011) in a cluster randomized control trial involving
over 900 patients admitted to 18 ICU, the use of ASC in addi-
tion to universal glove precautions pending ASC results, did
not reduce transmission of MRSA compared with existing
practice. The authors hypothesized that additional in-
terventions such as antiseptic bathing and improved envi-
ronmental decontamination may be needed (Huskins et al.,
2011). Another study conducted by the United States Veter-
ans Affairs in a system-wide quality improvement initiative
that looked at MRSA surveillance, contact precautions for
colonized and infected patients, hand hygiene along with
institutional culture change that sampled almost 2 million
patients in 150 hospitals (Jain et al., 2011). The program was
initially associated with a reduction in the rate of MRSA
infection in intensive care units by 62% and general units by
45%. However, it was not possible to determine whether ASC
was causally related to the observed drop in rates since thisdictive values of nasal MRSA colonization for prediction of
Negative predictive
value, % (95% CI)
Positive likelihood
ratio (95% CI)
Negative likelihood
ratio (95% CI)
68.39 (60.92e75.22) 2.12 (0.31e14.69) 0.98 (0.93e1.04)
67.61 (60.16e74.46) 0.00 1.01 (0.99e1.03)
68.39 (60e92e75.22) 1.43 (0.25e8.31) 0.99 (0.93e1.05)
nce interval; LRTI-lower respiratory tract infection; BSI-blood stream
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demonstrated marginal to MRSA reduction (Gurieva et al.,
2012). Our result did not show any difference in the rates of
MRSA associated infection between those who tested colo-
nized and not-colonized patients. This is consistent with
other studies which showed poor correlation between colo-
nized positivity and subsequent MRSA related infections
(Croft et al., 2009).5. Conclusion
The benefit of screening is still been debated. This study
showed no difference in the rates of MRSA infection between
those who tested colonized and not-colonized. However, data
from nasal colonization can be use to augment infection
control practices that aims to reduce MRSA burden in ICU
setting. We recommend clinicians should not use the results
of nasal swab colonization data alone to determine the need
for empiric antibiotics.
5.1. Limitations
Study was done in a single ICU setting and the findings may
not be applicable to other ICUs. Additionally this was a
retrospective study that has limited the availability of accu-
rate data due to documentation problems. We did not obtain
colonization samples from sites other than the nares in our
study. Finally the study was done in an ICU where an active
infection-control program is in place aimed at preventing the
transmission of MRSA, whichmay have influenced the results
of this study by limiting the overall occurrence of MRSA
colonization and infections. Hence larger, multicentered
prospective studies are required to evaluate the usefulness
and accuracy of MRSA screening in predicting subsequent
infections.
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